Open access
Open access
Powered by Google Translator Translator

Endocrinology

Guideline: Management of dyslipidemia for cardiovascular disease risk reduction

22 Sep, 2020 | 09:33h | UTC

Management of Dyslipidemia for Cardiovascular Disease Risk Reduction: Synopsis of the 2020 Updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline – Annals of Internal Medicine

Summary: VA/DoD Guidelines on Dyslipidemia Recommend Against Frequent LDL Testing – NEJM Journal Watch

 

Commentary on Twitter

 


Clinical update: Hormonal contraception in women with hypertension

22 Sep, 2020 | 09:32h | UTC

Hormonal Contraception in Women With Hypertension – JAMA (free for a limited period)

 

Commentary on Twitter

 


Lifelong aspirin for all in the secondary prevention of chronic coronary syndrome: Still sacrosanct or is reappraisal warranted?

17 Sep, 2020 | 09:19h | UTC

Lifelong Aspirin for All in the Secondary Prevention of Chronic Coronary Syndrome: Still Sacrosanct or is Reappraisal Warranted? – Circulation (free for a limited period)

 


Multisystem effects of COVID-19: A concise review for practitioners

16 Sep, 2020 | 09:14h | UTC

Multisystem effects of COVID-19: A concise review for practitioners – Postgraduate Medicine

 


Why COVID-19 is more deadly in people with obesity—even if they’re young

10 Sep, 2020 | 09:47h | UTC

Why COVID-19 is more deadly in people with obesity—even if they’re young – Science

 


How good a diet is intermittent fasting?

10 Sep, 2020 | 09:30h | UTC

How Good a Diet Is Intermittent Fasting? – Scientific American

 


WHO: More than 3 billion people protected from harmful trans-fat in their food

10 Sep, 2020 | 09:25h | UTC

More than 3 billion people protected from harmful trans fat in their food – World Health Organization

Report: Countdown to 2023: WHO report on global trans-fat elimination 2020 – World Health Organization

 

Commentary on Twitter

 


Podcast: Update on bariatric surgery—2020

9 Sep, 2020 | 09:18h | UTC

Audio Clinical Review: Update on Bariatric Surgery—2020 – JAMA

 


Systematic review: Reduction in saturated fat intake for cardiovascular disease

8 Sep, 2020 | 01:07h | UTC

Reduction in saturated fat intake for cardiovascular disease – Cochrane Library

Summary: Effect of cutting down on the saturated fat we eat on our risk of heart disease – Cochrane Library

 


[Abstract Only] Meta-analysis: Effect of alternate-day fasting on obesity and cardiometabolic risk

6 Sep, 2020 | 21:24h | UTC

Effect of alternate-day fasting on obesity and cardiometabolic risk: A systematic review and meta-analysis – Metabolism

Source: EvidenceAlerts

 


Case report: Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection

4 Sep, 2020 | 02:10h | UTC

Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report – Nature Metabolism

Commentary: Can COVID-19 cause diabetes? – MedicalXpress

 

Commentary on Twitter

 


ADA Guideline synopsis: Pharmacologic approaches to glycemic treatment of Type 2 Diabetes

2 Sep, 2020 | 09:41h | UTC

Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association’s Standards of Medical Care in Diabetes Clinical Guideline – Annals of Internal Medicine

 


#ESCCongress – [Abstract Only] Randomized trial: Cardiovascular and renal outcomes with Empagliflozin in heart failure

31 Aug, 2020 | 01:38h | UTC

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure – New England Journal of Medicine

Commentaries: EMPEROR-Reduced: Empagliflozin Cuts Hospitalizations, CV Mortality in HFrEF – TCTMD AND EMPEROR-Reduced meets primary endpoint in heart failure with reduced ejection fraction – European Society of Cardiology AND Empagliflozin Outcome Trial in Patients With Chronic Heart Failure and a Reduced Ejection Fraction – EMPEROR-Reduced – American College of Cardiology

Related study: Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction – New England Journal of Medicine

 

Commentary on Twitter

 


#ESCCongress – [Abstract Only] SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: A meta-analysis of the EMPEROR-Reduced and DAPA-HF trials

31 Aug, 2020 | 01:36h | UTC

SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials – The Lancet

 


Individuals with obesity and COVID‐19: A global perspective on the epidemiology and biological relationships

27 Aug, 2020 | 09:57h | UTC

Individuals with obesity and COVID‐19: A global perspective on the epidemiology and biological relationships – Obesity Reviews

Commentaries: Obesity increases risk of complications from Covid-19, damages vaccine efficacy, study finds – CNN AND Obesity increases risk of Covid-19 death by 48%, study finds – The Guardian AND Obesity linked with higher risk for COVID-19 complications – University of North Carolina at Chapel Hill

 


[Abstract Only] Randomized trial: Closed-loop control in children with type 1 diabetes

27 Aug, 2020 | 09:45h | UTC

A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes – New England Journal of Medicine

Commentary: Artificial pancreas effectively controls type 1 diabetes in children age 6 and up – NIH News Releases

 


Effects of diet versus gastric bypass on metabolic function in diabetes

21 Aug, 2020 | 02:22h | UTC

Effects of Diet versus Gastric Bypass on Metabolic Function in Diabetes – New England Journal of Medicine

Commentaries: ‘Nearly identical’ metabolic benefits with surgery vs diet in people with type 2 diabetes – medwireNews AND Benefit of Gastric Bypass? It’s the Weight Loss – Physician’s Weekly

 


New-onset type 1 diabetes in children during COVID-19 pandemic

19 Aug, 2020 | 09:38h | UTC

New-Onset Type 1 Diabetes in Children During COVID-19: Multicenter Regional Findings in the U.K – Diabetes Care

Commentaries: COVID-19 linked to increase in type 1 diabetes in children – Imperial College London AND Expert reaction to study linking COVID-19 to increase in type 1 diabetes in children – Science Media Centre

 


Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England

16 Aug, 2020 | 22:26h | UTC

Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study – The Lancet Diabetes & Endocrinology

Related Study: Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study – The Lancet Diabetes & Endocrinology

 

Commentary on Twitter

 


Meta-analysis: The impact of obesity on severe disease and mortality in people with SARS‐CoV‐2

16 Aug, 2020 | 22:20h | UTC

The impact of obesity on severe disease and mortality in people with SARS‐CoV‐2: A systematic review and meta‐analysis – Endocrinology, Diabetes & Metabolism

 


Obesity and mortality among patients diagnosed with COVID-19

16 Aug, 2020 | 22:16h | UTC

Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization – Annals of Internal Medicine

Editorial: COVID-19 and Severe Obesity: A Big Problem?

Summary for Patients: Obesity and Risk for Adverse Outcomes Among Patients Diagnosed With COVID-19

Commentary: Obesity Raises the Risk of Death From Covid-19 Among Men – The New York Times

 


Will the COVID-19 pandemic worsen the obesity epidemic?

16 Aug, 2020 | 22:19h | UTC

Will the COVID-19 pandemic worsen the obesity epidemic? – Nature Reviews Endocrinology

Commentary: Lockdowns and business closures could fuel the rise of obesity, warn researchers – News Medical

 


Cohort Study: Overweight, obesity, and risk of hospitalization for COVID-19

16 Aug, 2020 | 22:15h | UTC

Overweight, obesity, and risk of hospitalization for COVID-19: A community-based cohort study of adults in the United Kingdom – Proceedings of the National Academy of Sciences

Commentary: COVID-19: Hospitalization significantly higher for those overweight – University College London AND Study: Obesity increases risk of hospitalization for COVID-19 patients – UPI

 


Systematic review: Metformin vs. the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome

16 Aug, 2020 | 22:11h | UTC

Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome – Cochrane Library

Summary: Metformin versus the combined oral contraceptive pill for excessive facial/body hair, acne, and menstrual disorders in polycystic ovary syndrome – Cochrane Library

 


A pragmatic approach to inpatient diabetes management during the COVID-19 pandemic

12 Aug, 2020 | 02:23h | UTC

A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic – The Journal of Clinical Endocrinology & Metabolism

 


Stay Updated in Your Specialty

 

No spam, just news.